🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of BCMA CART cell...
Status
Unknown
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Start Date
2018-06-02
Trial ID
NCT03767725
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-01-29
Trial ID
NCT00053989
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2018-06-18
Trial ID
NCT03434704
This phase II trial is studying how well giving combination chemotherapy to...
Status
Completed
Location
SWOG
Start Date
2005-06
Trial ID
NCT00121199
The study aims to compare two application forms (pre-filled syringe and On-...
Status
Completed
Location
Research Site
Start Date
2018-06-25
Trial ID
NCT03619993
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-03-08
Trial ID
NCT01022138
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
RATIONALE: Antiemetic drugs, such as aprepitant, may help lessen or prevent...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2005-08
Trial ID
NCT00719173
Treatments Being Tested